Direct analysis of tumor-associated peptide antigens

This publication has 46 references indexed in Scilit:

• Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell Lines
  Science, 1994
• T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells.
  The Journal of Experimental Medicine, 1994
• p21‐ras‐peptide‐specific T‐cell responses in a patient with colorectal cancer. CD4⁺ and CD8⁺ T cells recognize a peptide corresponding to a common mutation (13Gly → Asp)
  International Journal of Cancer, 1994
• Cytotoxic T Cells Isolated from Ovarian Malignant Ascites Recognize a Peptide Derived from the HER-2/neu Proto-oncogene
  Cellular Immunology, 1993
• Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
  European Journal of Immunology, 1993
• A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.
  The Journal of Experimental Medicine, 1992
• A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
  Science, 1991
• Antigen Recognition by Class I-Restricted T Lymphocytes
  Annual Review of Immunology, 1989
• Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma
  New England Journal of Medicine, 1988
• Vitiligo in patients with metastatic melanoma: A good prognostic sign
  Journal of the American Academy of Dermatology, 1983